Literature DB >> 7506420

Cellular adaptation to opiates alters ion-channel mRNA levels.

S A Mackler1, J H Eberwine.   

Abstract

The chronic use of several drugs, including opiates, results in the stereotypical behaviors characteristic of addiction. Alterations in gene expression have been associated with the use of these addictive drugs. Previous studies, however, have been limited to describing changes in amounts of individual mRNAs from single tissue samples. Cellular adaptation to opiates, reflected in the regulation of the expression of many different mRNAs, seems likely to contribute to the complicated behaviors of addiction. The present studies examined coordinate alterations in the amounts of multiple mRNAs in the rat striatum and in NG108-15 cells after opioid stimulation or the precipitated withdrawal of opioid use. The experimental approach combined amplification of the poly(A)+ RNA population with reverse Northern blot analysis to simultaneously characterize the relative changes in several mRNAs. Morphine treatment of rats for 5 days was associated with a reduction in the amount of striatal RNA for the voltage-sensitive K+ channel without significant changes in other ion channels. In NG108-15 cells stimulation with the delta-opiate receptor agonist [D-Ala2,D-Leu5]enkephalin (DADLE) alone and followed by naloxone (precipitated withdrawal) caused relative changes in the abundances of several mRNAs. The composite effects of alterations in the abundance of multiple mRNAs (and the proteins they encode) in response to opioid use likely contribute to the development and maintenance of opiate-mediated behaviors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7506420      PMCID: PMC42952          DOI: 10.1073/pnas.91.1.385

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Cellular mechanisms of opioid tolerance: studies in single brain neurons.

Authors:  M J Christie; J T Williams; R A North
Journal:  Mol Pharmacol       Date:  1987-11       Impact factor: 4.436

2.  Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process.

Authors:  P Y Law; D S Hom; H H Loh
Journal:  Mol Pharmacol       Date:  1982-07       Impact factor: 4.436

3.  A method for isolation of intact, translationally active ribonucleic acid.

Authors:  G Cathala; J F Savouret; B Mendez; B L West; M Karin; J A Martial; J D Baxter
Journal:  DNA       Date:  1983

4.  Opioid peptides selective for mu- and delta-opiate receptors reduce calcium-dependent action potential duration by increasing potassium conductance.

Authors:  M A Werz; R L MacDonald
Journal:  Neurosci Lett       Date:  1983-12-02       Impact factor: 3.046

5.  Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.

Authors:  P L Tao; P Y Law; H H Loh
Journal:  J Pharmacol Exp Ther       Date:  1987-03       Impact factor: 4.030

6.  Effects of cycloheximide and tunicamycin on opiate receptor activities in neuroblastoma X glioma NG108-15 hybrid cells.

Authors:  P Y Law; H G Ungar; D S Hom; H H Loh
Journal:  Biochem Pharmacol       Date:  1985-01-01       Impact factor: 5.858

7.  Morphine alters preproenkephalin gene expression.

Authors:  G R Uhl; J P Ryan; J P Schwartz
Journal:  Brain Res       Date:  1988-09-06       Impact factor: 3.252

8.  A neuroblastoma times glioma hybrid cell line with morphine receptors.

Authors:  W A Klee; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

9.  In situ transcription: specific synthesis of complementary DNA in fixed tissue sections.

Authors:  L H Tecott; J D Barchas; J H Eberwine
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

10.  Inhibition of the development of tolerance to morphine in rats by drugs which inhibit ribonucleic acid or protein synthesis.

Authors:  B M Cox; O H Osman
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

View more
  7 in total

1.  NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration.

Authors:  X Y Cha; R C Pierce; P W Kalivas; S A Mackler
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  Single cell transcriptomics of hypothalamic warm sensitive neurons that control core body temperature and fever response Signaling asymmetry and an extension of chemical neuroanatomy.

Authors:  James Eberwine; Tamas Bartfai
Journal:  Pharmacol Ther       Date:  2010-10-21       Impact factor: 12.310

3.  Osmo- and mechanosensitivity of the transient outward K+ current in a mammalian neuronal cell line.

Authors:  T J Schoenmakers; H Vaudry; L Cazin
Journal:  J Physiol       Date:  1995-12-01       Impact factor: 5.182

4.  Altered gene expression in the host brain caused by a trematode parasite: neuropeptide genes are preferentially affected during parasitosis.

Authors:  R M Hoek; R E van Kesteren; A B Smit; M de Jong-Brink; W P Geraerts
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

Review 5.  Drug targets: single-cell transcriptomics hastens unbiased discovery.

Authors:  Tamas Bartfai; Peter T Buckley; James Eberwine
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

6.  Effects of Compound 511 on BDNF-TrkB Signaling in the Mice Ventral Tegmental Area in Morphine-Induced Conditioned Place Preference.

Authors:  Han Zhang; Qisheng Wang; Qinmei Sun; Fenfen Qin; Dengyun Nie; Qian Li; Yun Gu; Yongwei Jiang; Shengfeng Lu; Zhigang Lu
Journal:  Cell Mol Neurobiol       Date:  2020-04-22       Impact factor: 5.046

7.  Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats.

Authors:  Sasha L Fulton; Swarup Mitra; Ashley E Lepack; Jennifer A Martin; Andrew F Stewart; Jacob Converse; Mason Hochstetler; David M Dietz; Ian Maze
Journal:  Neuropsychopharmacology       Date:  2022-01-29       Impact factor: 8.294

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.